Voyxact gets accelerated approval, offering investors a new entrant in the high-value kidney disease market. The Food and Drug Administration...
Approval
This latest approval further broadens global access to ProSense® and supports IceCure's commercial momentum following the U.S. Food and Drug...
Biomerica (NASDAQ:BMRA) has received approval from the UAE Ministry of Health and...
A Travere Therapeutics drug for a rare disease that can progress to kidney failure has converted its status to full...
